Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 1
2005 2
2007 1
2008 2
2009 2
2010 4
2011 4
2012 5
2013 8
2014 5
2015 6
2016 7
2017 6
2018 7
2019 2
2020 7
2021 13
2022 20
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.
Garutti M, Foffano L, Mazzeo R, Michelotti A, Da Ros L, Viel A, Miolo G, Zambelli A, Puglisi F. Garutti M, et al. Among authors: zambelli a. Genes (Basel). 2023 Apr 30;14(5):1025. doi: 10.3390/genes14051025. Genes (Basel). 2023. PMID: 37239385 Free PMC article. Review.
Trabectedin for the treatment of breast cancer.
D'Incalci M, Zambelli A. D'Incalci M, et al. Among authors: zambelli a. Expert Opin Investig Drugs. 2016;25(1):105-15. doi: 10.1517/13543784.2016.1124086. Epub 2015 Dec 22. Expert Opin Investig Drugs. 2016. PMID: 26592307 Review.
i2b2 to Optimize Patients Enrollment.
Bucalo M, Gabetta M, Chiudinelli L, Larizza C, Bellasi A, Zambelli A, Barbarini N. Bucalo M, et al. Among authors: zambelli a. Stud Health Technol Inform. 2021 May 27;281:506-507. doi: 10.3233/SHTI210217. Stud Health Technol Inform. 2021. PMID: 34042623
Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer.
Jacobs F, Agostinetto E, Miggiano C, De Sanctis R, Zambelli A, Santoro A. Jacobs F, et al. Among authors: zambelli a. Cancers (Basel). 2023 May 26;15(11):2933. doi: 10.3390/cancers15112933. Cancers (Basel). 2023. PMID: 37296893 Free PMC article. Review.
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Miglietta F, Cinquini M, Dieci MV, Cortesi L, Criscitiello C, Montemurro F, Del Mastro L, Zambelli A, Biganzoli L, Levaggi A, Delle Piane C, Marchiò C, Calabrese M, Fortunato L, Franco P, Meduri B, Fittipaldo VA, Gori S. Miglietta F, et al. Among authors: zambelli a. Breast. 2022 Dec;66:293-304. doi: 10.1016/j.breast.2022.10.014. Epub 2022 Oct 29. Breast. 2022. PMID: 36379199 Free PMC article. Review.
Opportunities and Challenges of Synthetic Data Generation in Oncology.
Jacobs F, D'Amico S, Benvenuti C, Gaudio M, Saltalamacchia G, Miggiano C, De Sanctis R, Della Porta MG, Santoro A, Zambelli A. Jacobs F, et al. Among authors: zambelli a. JCO Clin Cancer Inform. 2023 Aug;7:e2300045. doi: 10.1200/CCI.23.00045. JCO Clin Cancer Inform. 2023. PMID: 37535875 Free article. Review.
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors.
Zattarin E, Presti D, Mariani L, Sposetti C, Leporati R, Menichetti A, Corti C, Benvenuti C, Fucà G, Lobefaro R, Ligorio F, Provenzano L, Vingiani A, Del Vecchio M, Griguolo G, Sirico M, Bernocchi O, Marra A, Zagami P, Agostinetto E, Jacobs F, Di Mauro P, Esposito A, Giorgi CA, Lalli L, Boldrini L, Giacchetti PPB, Schianca AC, Guarneri V, Pedersini R, Losurdo A, Zambelli A, Generali D, Criscitiello C, Curigliano G, Pruneri G, de Braud F, Dieci MV, Vernieri C. Zattarin E, et al. Among authors: zambelli a. NPJ Breast Cancer. 2023 Apr 17;9(1):27. doi: 10.1038/s41523-023-00534-1. NPJ Breast Cancer. 2023. PMID: 37069173 Free PMC article.
118 results